This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for ManpowerGroup (MAN) in Q2 Earnings?
by Zacks Equity Research
ManpowerGroup's (MAN) second-quarter 2022 earnings and revenues are likely to have increased year over year.
Omnicom (OMC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Omnicom's (OMC) second-quarter 2022 earnings are likely to have increased year over year.
5 Broker-Favorite Stocks to Withstand the Current Market Mayhem
by Maharathi Basu
For significant returns, investors should keep broker-friendly stocks like C.H. Robinson (CHRW), Bunge Limited (BG), Cross Country Healthcare (CCRN), Bread Financial (BFH) and Commercial Metals Company (CMC) on their radar.
Cross Country Healthcare (CCRN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed the most recent trading day at $24.11, moving -1.11% from the previous trading session.
Cross Country (CCRN) Surges 8.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Cross Country (CCRN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
The Zacks Analyst Blog Highlights ZipRecruiter, Cross Country Healthcare, GEE Group and Resources Connection
by Zacks Equity Research
ZipRecruiter, Cross Country Healthcare, GEE Group and Resources Connection are part of Zacks top Analyst Blog
Cross Country Healthcare (CCRN) Just Overtook the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
4 Staffing Stocks to Watch on Robust Job Additions to Economy
by Ritujay Ghosh
The United States has been adding a record number of jobs, helping staffing firm stocks ZipRecruiter, Inc. (ZIP), Cross Country Healthcare, Inc. (CCRN), GEE Group, Inc. (JOB) and Resources Connection, Inc. (RGP).
Will Cross Country (CCRN) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cross Country (CCRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Stock Picks for Week of July 4, 2022
by Panel Of Zacks Experts
A Synopsis of Synopsys and a Healthcare Leader with a Diverse Client Base.
Here's Why You Should Retain Envestnet (ENV) Stock for Now
by Zacks Equity Research
Strong recurring revenue generation capacity and technology development boost Envestnet (ENV). However, lower liquidity is a concern.
Here's Why You Should Retain Insperity (NSP) Stock for Now
by Zacks Equity Research
Shareholder-friendly steps boost Insperity (NSP). However, lower liquidity is worrisome.
Accenture (ACN) Acquires Capabilities From Japan's Trancom ITS
by Zacks Equity Research
The acquisition is expected to strengthen Accenture's (ACN) digital engineering, manufacturing and logistics capabilities.
6 Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) efforts to capitalize on the rising opportunities in the professional employer organization industry look impressive. Acquisitions help boost revenue growth.
Cross Country Healthcare (CCRN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Cross Country Healthcare (CCRN) closed at $20.83, marking a +0.39% move from the previous day.
Why a Hold Strategy is Apt for ABM Industries (ABM) Stock Now
by Zacks Equity Research
ELEVATE is expected to significantly accelerate ABM Industries' (ABM) organic growth, improve its strategic and comprehensive positioning, and reinforce profitability.
FactSet (FDS) Rides on Robust Top Line, Low Liquidity Ails
by Zacks Equity Research
The recent buyout of CUSIP Global Services from S&P Global is expected to significantly boost FactSet's (FDS) open data strategy and expand its position in the global capital markets.
Reasons Why a Hold Strategy is Apt for Rollins (ROL) Stock Now
by Zacks Equity Research
Rollins (ROL) has a track record of consistent dividend payments.
Here's Why You Should Retain Booz Allen (BAH) Stock for Now
by Zacks Equity Research
Vision 2020 and a large addressable market boost Booz Allen (BAH). A weak capital position is, however, worrisome.
Accenture (ACN) to Gain From XtremeEDA Buyout: Here's How
by Zacks Equity Research
The deal is likely to help Accenture (ACN) expand its silicon design capabilities in Canada and the United States.
Boxlight (BOXL) Launches New AV Campus Communication Solution
by Zacks Equity Research
The move is a part of Boxlight's (BOXL) campus communication strategy.
Accenture (ACN), Johnson Controls to Operate Innovation Centers
by Zacks Equity Research
Accenture (ACN) will provide technologies like digital twins, 5G and Internet of Things, AI-driven analytics, and environmental information to Johnson Controls.
Boxlight (BOXL) Launches New Redesigned User-Friendly Website
by Zacks Equity Research
The move is a part of Boxlight's (BOXL) continuous drive toward becoming a leading provider of interactive technology solutions and services globally.
Why a Hold Strategy is Apt for IQVIA Holdings (IQV) Stock Now
by Zacks Equity Research
IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
Here's Why You Should Hold on to Accenture (ACN) Stock For Now
by Zacks Equity Research
Accenture (ACN) has been steadily gaining traction in its consulting as well as outsourcing businesses.